PREP – GREEN
9.75″ x 32.5″
14.5″ WHEEL BASE
PREP IS AN UNDERSTANDABLY LOADED CONVERSATION IN THE QUEER COMMUNITY. THE PRIVILEGED WESTERN WORLD HAS BEEN GRANTED ACCESS TO IT GRADUALLY. WHILE IT SAVES LIVES, IT ALSO PERPETUATES NON COMMUNICATION BETWEEN LOVERS AND PARTNERS ALIKE. THE OLD “DON’T ASK DON’T TELL” RULE FOR POLY FOLKS SHOULD BE A BRIGHT RED WARNING FLAG. NOW WHEN MAKING AN IMPULSIVE DECISION, THERE IS A SAFETY NET FOR CONTRACTING HIV. BEING IN CONTACT WITH REST OF THE STI SPECTRUM IS STILL A ROLL OF THE DICE. THE HISTORICAL SHAME ATTACHED TO BODIES WHO HAVE QUEER SEX IS LESSENING SLOWLY YEAR AFTER YEAR. GETTING REGULARLY TETSED AND INFORMING YOURSELF WILL ALWAYS BE IMPERATIVE TO HARM REDUCTION. SOME PEOPLE HAVE A HARD TIME DIGESTING THAT MAGIC BLUE PILL.
Pre-exposure prophylaxis (PrEP) is the use of medications used to prevent the spread of disease in people who have not yet been exposed to a disease-causing agent, usually a virus. The term typically refers to the specific use of antiviral drugs as a strategy for HIV/AIDS prevention. PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who also have a higher risk of acquiring HIV, including sexually active adults at increased risk of HIV, people who engage in injection drug use (see drug injection), and serodiscordant sexually active couples.
When used as directed, PrEP has been shown to be highly effective, reducing the risk of acquiring HIV up to 99%. As of 2019, the World Health Organization (WHO) recommends two drug combinations for the use as PrEP for HIV/AIDS: the combination of tenofovir disoproxil and emtricitabine (Truvada), or the combination of tenofovir disoproxil and lamivudine (Cimduo). In October 2019, the U.S. Food and Drug Administration (FDA) approved the combination of emtricitabine and tenofovir alafenamide (Descovy) to be used as PrEP in addition to Truvada, which provides similar levels of protection.
Out of stock